KR
₹57.93
-1.22(-2.06%)
KREBSBIO₹57.93-2.06%
47/100
0100 · strongest
moderatepartial
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %KREBSBIO financial summary
For Mar 2026, Krebs Biochemicals and Industries Limited reported revenue of ₹24 crore, which fell 44.2% from the previous year. Net profit was -₹17 crore, on an operating margin of -23%. Earnings per share came in at -₹7.85. Annual results are available for 14 financial years, from Jun 2013 to Mar 2026.
| Revenue | ₹24 crore |
|---|---|
| Net profit | -₹17 crore |
| Operating margin | -23% |
| EPS | -₹7.85 |